PropertyValue
?:abstract
  • A key tenet of protection from infection for dentists is to know who is not infectious. The evidence base regarding protection from respiratory pathogens in dentistry is poor. Those with a positive SARS-CoV-2 IgG antibody are non-infectious (>99% certainty) and can be safely treated with good universal precautions, even for aerosol generating procedures. Viral infectivity with SARS-CoV-2 lasts eight days, unlike viral polymerase chain reaction (PCR) swab tests which can persist for as long as seven weeks. SARS-CoV-2 IgG antibody becomes detectable from 11 days after infection. SARS-CoV-2 IgG antibodies are usually neutralising against the virus and their direct antiviral activity was partially demonstrated in 33,000 patients with COVID-19 treated with convalescent plasma in the USA. So, a positive SARS-CoV-2 IgG antibody is a much more accurate determination of infectiousness than a repeat PCR which is only 70% sensitive. It remains to be seen whether SARS-Cov-2 vaccine responses include protective IgG titres and, once vaccines become widespread, can be used to assist decision-making on appropriate personal protective equipment (PPE) in dentistry.
?:creator
?:doi
?:doi
  • 10.1038/s41415-020-2228-9
?:journal
  • Br_Dent_J
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/4aa070a9f48b0048c5924ea4ad971883500a5a2f.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7582419.xml.json
?:pmcid
?:pmid
?:pmid
  • 33097885.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2
?:type
?:year
  • 2020-10-23

Metadata

Anon_0  
expand all